Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386,127,219
-
Number of holders
-
155
-
Total 13F shares, excl. options
-
285,864,576
-
Shares change
-
+5,131,635
-
Total reported value, excl. options
-
$371,613,646
-
Value change
-
+$7,179,115
-
Put/Call ratio
-
32%
-
Number of buys
-
61
-
Number of sells
-
-62
-
Price
-
$1.30
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q3 2025
175 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q3 2025.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 285,864,576 shares
of 386,127,219 outstanding shares and own 74% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (77,558,856 shares), VIKING GLOBAL INVESTORS LP (58,651,170 shares), BlackRock, Inc. (24,920,918 shares), VANGUARD GROUP INC (17,245,583 shares), MAK CAPITAL ONE LLC (15,931,806 shares), Long Focus Capital Management, LLC (11,362,804 shares), GEODE CAPITAL MANAGEMENT, LLC (7,468,917 shares), STATE STREET CORP (6,402,649 shares), MORGAN STANLEY (6,355,152 shares), and Hollow Brook Wealth Management LLC (5,775,739 shares).
This table shows the top 155 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.